Depression
Conditions
Interventions
Intervention group:Basic treatment (Sertraline hydrochloride tablets + Shugan Jieyu capsules) + Baduanjin + Wuyin therapy
Control group:Basic treatment (Sertraline hydrochloride tablets + Shugan Jieyu capsules)
Sponsors
Tsinghua University Yuquan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for "Yu's disease" (liver qi stagnation and spleen deficiency syndrome) in traditional Chinese medicine; (2) Meet the diagnostic criteria for mild to moderate depressive episode according to Western medicine; (3) HAMD-17 score > 17 points, and Hamilton Anxiety Scale (HAMA) score < 7 points; (4) Participants aged 18 years or older and under 70 years of age; (5) Without other serious somatic diseases or psychological disorders; (6) Completed questionnaires and other relevant clinical data; (7) Participants who are conscious and willing to participate in the study and sign informed consent forms. Anyone who meets the above criteria can be included.
Exclusion criteria
Exclusion criteria: (1) Individuals with a history or present tendency towards suicide and/or suicide attempts; (2) Individuals with serious or chronic diseases of the heart, brain, lungs, liver, kidneys, or blood system, or patients with mental illness; (3) Individuals with a history of alcohol or drug abuse; (4) Individuals whose questionnaires are incomplete or whose relevant clinical information is incomplete; (5) Individuals who do not agree to participate in this study. Individuals who meet any of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate of disease treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heat value data of infrared heat map; | — |
Countries
China
Contacts
Public ContactQingjie Yuan
Tsinghua University Yuquan Hospital
Outcome results
None listed